Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma - PubMed (original) (raw)
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma
Ivan Pasic et al. Cancer Res. 2010.
Abstract
Osteosarcomas are copy number alteration (CNA)-rich malignant bone tumors. Using microarrays, fluorescence in situ hybridization, and quantitative PCR, we characterize a focal region of chr3q13.31 (osteo3q13.31) harboring CNAs in 80% of osteosarcomas. As such, osteo3q13.31 is the most altered region in osteosarcoma and contests the view that CNAs in osteosarcoma are nonrecurrent. Most (67%) osteo3q13.31 CNAs are deletions, with 75% of these monoallelic and frequently accompanied by loss of heterozygosity (LOH) in flanking DNA. Notably, these CNAs often involve the noncoding RNAs LOC285194 and BC040587 and, in some cases, a tumor suppressor gene that encodes the limbic system-associated membrane protein (LSAMP). Ubiquitous changes occur in these genes in osteosarcoma, usually involving loss of expression. Underscoring their functional significance, expression of these genes is correlated with the presence of osteo3q13.31 CNAs. Focal osteo3q13.31 CNAs and LOH are also common in cell lines from other cancers, identifying osteo3q13.31 as a generalized candidate region for tumor suppressor genes. Osteo3q13.31 genes may function as a unit, given significant correlation in their expression despite the great genetic distances between them. In support of this notion, depleting either LSAMP or LOC285194 promoted proliferation of normal osteoblasts by regulation of apoptotic and cell-cycle transcripts and also VEGF receptor 1. Moreover, genetic deletions of LOC285194 or BC040587 were also associated with poor survival of osteosarcoma patients. Our findings identify osteo3q13.31 as a novel region of cooperatively acting tumor suppressor genes.
Similar articles
- LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O, Meza-Zepeda LA. Kresse SH, et al. Genes Chromosomes Cancer. 2009 Aug;48(8):679-93. doi: 10.1002/gcc.20675. Genes Chromosomes Cancer. 2009. PMID: 19441093 - Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma.
Yen CC, Chen WM, Chen TH, Chen WY, Chen PC, Chiou HJ, Hung GY, Wu HT, Wei CJ, Shiau CY, Wu YC, Chao TC, Tzeng CH, Chen PM, Lin CH, Chen YJ, Fletcher JA. Yen CC, et al. Int J Oncol. 2009 Oct;35(4):775-88. doi: 10.3892/ijo_00000390. Int J Oncol. 2009. PMID: 19724913 - Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, Fleuren GJ, Jordanova ES. Kloth JN, et al. BMC Genomics. 2007 Feb 20;8:53. doi: 10.1186/1471-2164-8-53. BMC Genomics. 2007. PMID: 17311676 Free PMC article. - Genetic instability in osteoblastic tumors of the skeletal system.
Radig K, Schneider-Stock R, Mittler U, Neumann HW, Roessner A. Radig K, et al. Pathol Res Pract. 1998;194(10):669-77. doi: 10.1016/S0344-0338(98)80125-8. Pathol Res Pract. 1998. PMID: 9820862 Review. - Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor.
Kuijjer ML, Hogendoorn PC, Cleton-Jansen AM. Kuijjer ML, et al. Int J Cancer. 2013 Dec 1;133(11):2512-21. doi: 10.1002/ijc.28124. Epub 2013 Mar 16. Int J Cancer. 2013. PMID: 23436697 Review.
Cited by
- lncRNAs regulate cell stemness in physiology and pathology during differentiation and development.
Lu J, Xu L, Wang Y, Guan B. Lu J, et al. Am J Stem Cells. 2024 Apr 25;13(2):59-74. doi: 10.62347/VHVU7361. eCollection 2024. Am J Stem Cells. 2024. PMID: 38765805 Free PMC article. Review. - Bioinformatics analysis and experimental validation identified HMGA2/microRNA-200c-3p/LSAMP/Wnt axis as an immunological factor of patients with colorectal cancer.
Xu X, Gong C, Wang Y, Yin Z, Wang X, Hu Y, Fang Z. Xu X, et al. Am J Cancer Res. 2023 Sep 15;13(9):3898-3920. eCollection 2023. Am J Cancer Res. 2023. PMID: 37818072 Free PMC article. - Identification of two novel lipid metabolism-related long non-coding RNAs (SNHG17 and LINC00837) as potential signatures for osteosarcoma prognosis and precise treatment.
Tang Z, Feng H, Shu L, Guo M, Qi B, Pu L, Shi H, Ren J, Li C. Tang Z, et al. BMC Med Genomics. 2023 May 25;16(1):115. doi: 10.1186/s12920-023-01553-4. BMC Med Genomics. 2023. PMID: 37231440 Free PMC article. - Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma.
Martinez-Monleon A, Gaarder J, Djos A, Kogner P, Fransson S. Martinez-Monleon A, et al. Int J Oncol. 2023 Feb;62(2):27. doi: 10.3892/ijo.2023.5475. Epub 2023 Jan 5. Int J Oncol. 2023. PMID: 36601748 Free PMC article. - Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma.
Taylor AM, Sun JM, Yu A, Voicu H, Shen J, Barkauskas DA, Triche TJ, Gastier-Foster JM, Man TK, Lau CC. Taylor AM, et al. Int J Mol Sci. 2022 Jul 21;23(14):8036. doi: 10.3390/ijms23148036. Int J Mol Sci. 2022. PMID: 35887382 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials